Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study.

Guthrie KA, Caan B, Diem S, Ensrud KE, Greaves SR, Larson JC, Newton KM, Reed SD, LaCroix AZ.

Clin Trials. 2019 May 6:1740774519846862. doi: 10.1177/1740774519846862. [Epub ahead of print]

PMID:
31055949
2.

Confirmatory factor analysis of the Insomnia Severity Index (ISI) and invariance across race: a pooled analysis of MsFLASH data.

Otte JL, Bakoyannis G, Rand KL, Ensrud KE, Guthrie KA, Joffe H, McCurry SM, Newton KM, Carpenter JS.

Menopause. 2019 Aug;26(8):850-855. doi: 10.1097/GME.0000000000001343.

PMID:
30994570
3.

Early Pregnancy Hemoglobin A1C and Pregnancy Outcomes: A Population-Based Study.

Chen L, Pocobelli G, Yu O, Shortreed SM, Osmundson SS, Fuller S, Wartko PD, Mcculloch D, Warwick S, Newton KM, Dublin S.

Am J Perinatol. 2019 Aug;36(10):1045-1053. doi: 10.1055/s-0038-1675619. Epub 2018 Nov 30.

4.

One-Step Approach to Identifying Gestational Diabetes Mellitus: Association With Perinatal Outcomes.

Pocobelli G, Yu O, Fuller S, Fraser JR, Wartko PD, Chen L, Newton KM, Dimer J, McCulloch DK, Warwick S, Dublin S.

Obstet Gynecol. 2018 Oct;132(4):859-867. doi: 10.1097/AOG.0000000000002780.

PMID:
30130344
5.

Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.

Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, LaCroix AZ, Caan B, Guthrie KA.

JAMA Intern Med. 2018 May 1;178(5):681-690. doi: 10.1001/jamainternmed.2018.0116.

6.

Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials.

Guthrie KA, Larson JC, Ensrud KE, Anderson GL, Carpenter JS, Freeman EW, Joffe H, LaCroix AZ, Manson JE, Morin CM, Newton KM, Otte J, Reed SD, McCurry SM.

Sleep. 2018 Jan 1;41(1). doi: 10.1093/sleep/zsx190.

7.

Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.

Miller LM, Lampe JW, Newton KM, Gundersen G, Fuller S, Reed SD, Frankenfeld CL.

Maturitas. 2017 May;99:37-42. doi: 10.1016/j.maturitas.2017.02.006. Epub 2017 Feb 16.

PMID:
28364866
8.

High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network.

Karter AJ, Lipska KJ, O'Connor PJ, Liu JY, Moffet HH, Schroeder EB, Lawrence JM, Nichols GA, Newton KM, Pathak RD, Desai J, Waitzfelder B, Butler MG, Thomas A, Steiner JF; SUPREME-DM Study Group.

J Diabetes Complications. 2017 May;31(5):869-873. doi: 10.1016/j.jdiacomp.2017.02.009. Epub 2017 Feb 21.

9.

Acceptability of a team-based mobile health (mHealth) application for lifestyle self-management in individuals with chronic illnesses.

Hartzler AL, Venkatakrishnan A, Mohan S, Silva M, Lozano P, Ralston JD, Ludman E, Rosenberg D, Newton KM, Nelson L, Pirolli P.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3277-3281. doi: 10.1109/EMBC.2016.7591428.

PMID:
28269007
10.

Estimating Burdens of Neglected Tropical Zoonotic Diseases on Islands with Introduced Mammals.

de Wit LA, Croll DA, Tershy B, Newton KM, Spatz DR, Holmes ND, Kilpatrick AM.

Am J Trop Med Hyg. 2017 Mar;96(3):749-757. doi: 10.4269/ajtmh.16-0573. Epub 2017 Apr 6.

11.

We still have a long way to go.

Newton KM.

Menopause. 2017 Jan;24(1):3-4. doi: 10.1097/GME.0000000000000797. No abstract available.

PMID:
27824685
12.

Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN).

Reynolds K, Go AS, Leong TK, Boudreau DM, Cassidy-Bushrow AE, Fortmann SP, Goldberg RJ, Gurwitz JH, Magid DJ, Margolis KL, McNeal CJ, Newton KM, Novotny R, Quesenberry CP Jr, Rosamond WD, Smith DH, VanWormer JJ, Vupputuri S, Waring SC, Williams MS, Sidney S.

Am J Med. 2017 Mar;130(3):317-327. doi: 10.1016/j.amjmed.2016.09.014. Epub 2016 Oct 14.

13.

Effects of Yoga and Aerobic Exercise on Actigraphic Sleep Parameters in Menopausal Women with Hot Flashes.

Buchanan DT, Landis CA, Hohensee C, Guthrie KA, Otte JL, Paudel M, Anderson GL, Caan B, Freeman EW, Joffe H, LaCroix AZ, Newton KM, Reed SD, Ensrud KE.

J Clin Sleep Med. 2017 Jan 15;13(1):11-18. doi: 10.5664/jcsm.6376.

14.

Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis.

Carpenter JS, Jones SM, Studts CR, Heiman JR, Reed SD, Newton KM, Guthrie KA, Larson JC, Cohen LS, Freeman EW, Jane Lau R, Learman LA, Shifren JL.

Arch Sex Behav. 2016 Nov;45(8):1897-1905. Epub 2016 Aug 8.

15.

A yoga & exercise randomized controlled trial for vasomotor symptoms: Effects on heart rate variability.

Jones SM, Guthrie KA, Reed SD, Landis CA, Sternfeld B, LaCroix AZ, Dunn A, Burr RL, Newton KM.

Complement Ther Med. 2016 Jun;26:66-71. doi: 10.1016/j.ctim.2016.03.001. Epub 2016 Mar 4.

16.

Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.

McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Tinker LF, LaCroix AZ.

JAMA Intern Med. 2016 Jul 1;176(7):913-20. doi: 10.1001/jamainternmed.2016.1795.

17.

Is heart rate variability associated with frequency and intensity of vasomotor symptoms among healthy perimenopausal and postmenopausal women?

Jones SM, Guthrie KA, LaCroix AZ, Sternfeld B, Landis CA, Reed SD, Dunn A, Caan B, Cohen LS, Hunt J, Newton KM.

Clin Auton Res. 2016 Feb;26(1):7-13. doi: 10.1007/s10286-015-0322-x. Epub 2015 Dec 21.

18.

Daily salivary cortisol patterns in midlife women with hot flashes.

Reed SD, Newton KM, Larson JC, Booth-LaForce C, Woods NF, Landis CA, Tolentino E, Carpenter JS, Freeman EW, Joffe H, Anawalt BD, Guthrie KA.

Clin Endocrinol (Oxf). 2016 May;84(5):672-9. doi: 10.1111/cen.12995. Epub 2016 Jan 26.

19.

MsFLASH participants' priorities for alleviating menopausal symptoms.

Carpenter JS, Woods NF, Otte JL, Guthrie KA, Hohensee C, Newton KM, Joffe H, Cohen L, Sternfeld B, Lau RJ, Reed SD, LaCroix AZ.

Climacteric. 2015;18(6):859-66. doi: 10.3109/13697137.2015.1083003. Epub 2015 Oct 30.

20.

Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.

Lafata JE, Karter AJ, O'Connor PJ, Morris H, Schmittdiel JA, Ratliff S, Newton KM, Raebel MA, Pathak RD, Thomas A, Butler MG, Reynolds K, Waitzfelder B, Steiner JF.

J Gen Intern Med. 2016 Feb;31(2):188-195. doi: 10.1007/s11606-015-3486-0.

21.

Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.

Guthrie KA, LaCroix AZ, Ensrud KE, Joffe H, Newton KM, Reed SD, Caan B, Carpenter JS, Cohen LS, Freeman EW, Larson JC, Manson JE, Rexrode K, Skaar TC, Sternfeld B, Anderson GL.

Obstet Gynecol. 2015 Aug;126(2):413-22. doi: 10.1097/AOG.0000000000000927.

22.

Methods for engaging stakeholders in comparative effectiveness research: a patient-centered approach to improving diabetes care.

Schmittdiel JA, Desai J, Schroeder EB, Paolino AR, Nichols GA, Lawrence JM, O'Connor PJ, Ohnsorg KA, Newton KM, Steiner JF.

Healthc (Amst). 2015 Jun;3(2):80-8. doi: 10.1016/j.hjdsi.2015.02.005. Epub 2015 Mar 13.

23.

An Innovative Approach to Informing Research: Gathering Perspectives on Diabetes Care Challenges From an Online Patient Community.

Schroeder EB, Desai J, Schmittdiel JA, Paolino AR, Schneider JL, Goodrich GK, Lawrence JM, Newton KM, Nichols GA, O'Connor PJ, Fitz-Randolph M, Steiner JF.

Interact J Med Res. 2015 Jun 30;4(2):e13. doi: 10.2196/ijmr.3856.

24.

Confirmatory factor analysis of the Pittsburgh Sleep Quality Index in women with hot flashes.

Otte JL, Rand KL, Landis CA, Paudel ML, Newton KM, Woods N, Carpenter JS.

Menopause. 2015 Nov;22(11):1190-6. doi: 10.1097/GME.0000000000000459.

25.

Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011.

Schroeder EB, Powers JD, O'Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, Lafata JE, Reynolds K, Thomas A, Waitzfelder BE, Steiner JF; SUPREME-DM Study Group.

J Diabetes Complications. 2015 Jul;29(5):637-43. doi: 10.1016/j.jdiacomp.2015.04.007. Epub 2015 Apr 16.

PMID:
25936953
26.

Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH Analysis.

Carpenter JS, Reed SD, Guthrie KA, Larson JC, Newton KM, Lau RJ, Learman LA, Shifren JL.

Sex Med. 2015 Mar;3(1):7-13. doi: 10.1002/sm2.53.

27.

Response to comment on O'Connor et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes care 2014;37:3317-3324.

O'Connor PJ, Schmittdiel JA, Pathak RD, Harris RI, Newton KM.

Diabetes Care. 2015 Mar;38(3):e46. doi: 10.2337/dc14-2928. No abstract available.

28.

Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.

Vazquez-Benitez G, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Butler MG, Karter AJ, Steiner JF, Newton KM, Morales LS, Pathak RD, Thomas A, Reynolds K, Kirchner HL, Waitzfelder B, Elston Lafata J, Adibhatla R, Xu Z, O'Connor PJ.

Diabetes Care. 2015 May;38(5):905-12. doi: 10.2337/dc14-1877. Epub 2015 Feb 20.

29.

Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors.

Freeman EW, Ensrud KE, Larson JC, Guthrie KA, Carpenter JS, Joffe H, Newton KM, Sternfeld B, LaCroix AZ.

Psychosom Med. 2015 Feb-Mar;77(2):167-75. doi: 10.1097/PSY.0000000000000143.

30.

Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation.

Thacker EL, Jensen PN, Psaty BM, McKnight B, Longstreth WT Jr, Dublin S, Newton KM, Smith NL, Siscovick DS, Heckbert SR.

Ann Pharmacother. 2015 Apr;49(4):378-86. doi: 10.1177/1060028014568447. Epub 2015 Jan 27.

31.

Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States.

Hullar MA, Lancaster SM, Li F, Tseng E, Beer K, Atkinson C, Wähälä K, Copeland WK, Randolph TW, Newton KM, Lampe JW.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):546-54. doi: 10.1158/1055-9965.EPI-14-0262. Epub 2014 Dec 26.

32.

Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project.

Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O'Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Lafata JE, Butler MG, Kirchner HL, Thomas A, Steiner JF; SUPREME-DM Study Group.

Am J Epidemiol. 2015 Jan 1;181(1):32-9. doi: 10.1093/aje/kwu255. Epub 2014 Dec 16.

33.

Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.

Malinowski JR, Denny JC, Bielinski SJ, Basford MA, Bradford Y, Peissig PL, Carrell D, Crosslin DR, Pathak J, Rasmussen L, Pacheco J, Kho A, Newton KM, Li R, Kullo IJ, Chute CG, Chisholm RL, Jarvik GP, Larson EB, McCarty CA, Masys DR, Roden DM, de Andrade M, Ritchie MD, Crawford DC.

PLoS One. 2014 Dec 1;9(12):e111301. doi: 10.1371/journal.pone.0111301. eCollection 2014.

34.

Associations between Dietary Intake of Fruits and Vegetables in relation to Urinary Estrogen DNA Adduct Ratio.

Reding KW, Zahid M, Cavalieri E, Rogan EG, Raccor BS, Atkinson C, Yong M, Newton KM, Lampe JW.

Open J Prev Med. 2014 Jun;4(6):429-437.

35.

A cross-sectional study of equol producer status and self-reported vasomotor symptoms.

Newton KM, Reed SD, Uchiyama S, Qu C, Ueno T, Iwashita S, Gunderson G, Fuller S, Lampe JW.

Menopause. 2015 May;22(5):489-95. doi: 10.1097/GME.0000000000000363.

PMID:
25380274
36.

Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.

Ensrud KE, Guthrie KA, Hohensee C, Caan B, Carpenter JS, Freeman EW, LaCroix AZ, Landis CA, Manson J, Newton KM, Otte J, Reed SD, Shifren JL, Sternfeld B, Woods NF, Joffe H.

Sleep. 2015 Jan 1;38(1):97-108. doi: 10.5665/sleep.4332.

37.

Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes.

O'Connor PJ, Schmittdiel JA, Pathak RD, Harris RI, Newton KM, Ohnsorg KA, Heisler M, Sterrett AT, Xu S, Dyer WT, Raebel MA, Thomas A, Schroeder EB, Desai JR, Steiner JF.

Diabetes Care. 2014 Dec;37(12):3317-24. doi: 10.2337/dc14-0596. Epub 2014 Oct 14.

38.

Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies.

Schroeder EB, Goodrich GK, Newton KM, Schmittdiel JA, Raebel MA.

J Comp Eff Res. 2014 Jul;3(4):359-69. doi: 10.2217/cer.14.25.

PMID:
25275233
39.

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD.

Respir Med. 2014 Nov;108(11):1626-32. doi: 10.1016/j.rmed.2014.08.009. Epub 2014 Sep 2.

40.

Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.

Reed SD, Mitchell CM, Joffe H, Cohen L, Shifren JL, Newton KM, Freeman EW, Larson JC, Manson JE, LaCroix AZ, Guthrie KA.

Obstet Gynecol. 2014 Aug;124(2 Pt 1):233-41. doi: 10.1097/AOG.0000000000000386.

41.

But does it work in women like me?

Newton KM.

Menopause. 2014 Aug;21(8):786-7. doi: 10.1097/GME.0000000000000289. No abstract available.

PMID:
24983273
42.

Isoflavones hold limited promise for the treatment of menopausal vasomotor symptoms.

Newton KM.

Evid Based Med. 2014 Oct;19(5):178. doi: 10.1136/ebmed-2014-110000. Epub 2014 Jun 17. No abstract available.

PMID:
24939922
43.

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.

Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, Carpenter JS, Cohen L.

JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891.

44.

The biogeography of globally threatened seabirds and island conservation opportunities.

Spatz DR, Newton KM, Heinz R, Tershy B, Holmes ND, Butchart SH, Croll DA.

Conserv Biol. 2014 Oct;28(5):1282-90. doi: 10.1111/cobi.12279. Epub 2014 Mar 24.

PMID:
24661307
45.

Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.

Raebel MA, Ellis JL, Schroeder EB, Xu S, O'Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Nichols GA, Newton KM, Pathak RD, Steiner JF.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):699-710. doi: 10.1002/pds.3610. Epub 2014 Mar 18.

PMID:
24639086
46.

Factors associated with successful discontinuation of hormone therapy.

Newton KM, Reed SD, Nekhyludov L, Grothaus LC, Ludman EJ, Ehrlich K, LaCroix AZ.

J Womens Health (Larchmt). 2014 May;23(5):382-8. doi: 10.1089/jwh.2012.4200. Epub 2014 Jan 20.

47.

Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study.

Raebel MA, Xu S, Goodrich GK, Schroeder EB, Schmittdiel JA, Segal JB, O'Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Elston Lafata J, Butler M, Newton KM, Steiner JF.

Ann Pharmacother. 2013 Oct;47(10):1280-91. doi: 10.1177/1060028013503624.

PMID:
24259692
48.

Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.

Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-LaForce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE, Freeman EW, Hunt JR, Joffe H, Larson JC, Learman LA, Rothenberg R, Seguin RA, Sherman KJ, Sternfeld BS, LaCroix AZ.

Am J Obstet Gynecol. 2014 Mar;210(3):244.e1-11. doi: 10.1016/j.ajog.2013.11.016. Epub 2013 Nov 8.

49.

Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.

Newton KM, Reed SD, Guthrie KA, Sherman KJ, Booth-LaForce C, Caan B, Sternfeld B, Carpenter JS, Learman LA, Freeman EW, Cohen LS, Joffe H, Anderson GL, Larson JC, Hunt JR, Ensrud KE, LaCroix AZ.

Menopause. 2014 Apr;21(4):339-46. doi: 10.1097/GME.0b013e31829e4baa.

50.

Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.

Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE, Sternfeld B, Caan B, Freeman EW, LaCroix AZ, Tinker LF, Booth-Laforce C, Larson JC, Anderson GL.

Menopause. 2014 Apr;21(4):347-54. doi: 10.1097/GME.0b013e31829e40b8.

Supplemental Content

Loading ...
Support Center